Page last updated: 2024-11-04

temozolomide and Intellectual Disability

temozolomide has been researched along with Intellectual Disability in 1 studies

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TMZ) is a first-line chemotherapeutic agent for the treatment of glioma."8.12The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis. ( Duan, S; Gong, F; Li, Q; Wei, Y, 2022)
"Temozolomide (TMZ) is a first-line chemotherapeutic agent for the treatment of glioma."4.12The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis. ( Duan, S; Gong, F; Li, Q; Wei, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wei, Y1
Duan, S1
Gong, F1
Li, Q1

Other Studies

1 other study available for temozolomide and Intellectual Disability

ArticleYear
The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
    Biochemical and biophysical research communications, 2022, 05-07, Volume: 603

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation;

2022